Condition (MeSH)
Aneuploidy
ClinicalTrials.gov lists 77 trials for Aneuploidy or a narrower condition beneath it. Sequenom, Inc. has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
69 of the 77 trials are tagged with Aneuploidy itself; the rest are tagged with a narrower condition beneath it.
When did Aneuploidy trials start? (21)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 4 |
| 2025 | 5 |
| 2024 | 3 |
| 2023 | 2 |
| 2022 | 4 |
| 2021 | 6 |
| 2020 | 5 |
| 2019 | 5 |
| 2018 | 4 |
| 2017 | 2 |
Showing 10 of 21 earlier years.
No forecast is made for this condition: it averages 4.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Aneuploidy trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 4 |
| Phase 4 | 4 |
| Not applicable | 27 |
| Observational | 42 |
How many Aneuploidy trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 9 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 3 |
| Completed | 39 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Aneuploidy trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Sequenom, Inc. | 6 |
| Igenomix | 5 |
| National Human Genome Research Institute (NHGRI) | 3 |
| Cindy Cisneros | 2 |
| Natera, Inc. | 2 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Aneuploidy? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| CoQ10 | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| BLOOD SAMPLES | 1 |
| Gonadotrophins | 1 |
| Non intervention | 1 |
| Ovarian stimulation | 1 |
| Blood Test | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Aneuploidy? (275)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Reassessing the conventional fertilization check: leveraging preimplantation genetic testing for aneuploidy to increase the number of transferrable embryos. | Reproductive biomedicine online | 2025 | Yes |
| Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study. | Reproductive biology and endocrinology : RB&E | 2025 | Yes |
| Non-invasive preimplantation genetic testing for aneuploidy using cell-free DNA in blastocyst culture medium. | Journal of assisted reproduction and genetics | 2025 | Yes |
| A randomized controlled trial of counseling and educational methods on preimplantation genetic testing for aneuploidy for patients pursuing in vitro fertilization. | Fertility and sterility | 2025 | Yes |
| Healthy euploid dizygotic twin birth after transfer of nonmosaic aneuploid embryos. | Fertility and sterility | 2025 | Yes |
Showing 5 of 275 publications.
Sub-conditions in MeSH (3)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.